JARDIANCE 25 mg, film-coated tablet 30 tablets
Active ingredients: Empagliflozin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JARDIANCE 25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Diabète non insulino-dépendant (de"type gras"), en association avec de la metformine, ou avec un sulfamide hypoglycémiant, ou avec la metformine et un sulfamide hypoglycémiant, ou avec la metformine et l'insuline. ; JOURNAL OFFICIEL ; 19/03/21
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69963066CIP72789291CIP133400927892912Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMPAGLIFLOZINEcomprimé | 25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.